Medicure (MCUJF) EBITDA (2009 - 2026)

Medicure's EBITDA history runs 18 years deep, the most recent figure standing at $178655.4 for Q1 2026.

• In Q1 2026, EBITDA rose 135.65% year-over-year to $178655.4; the TTM figure through Mar 2026 stood at -$10.2 million (down 1968.57% YoY), while the FY2025 annual figure was -$5.7 million, down 1268.93% from the prior year.
• EBITDA was $178655.4 for Q1 2026 at Medicure, up from -$8.3 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $4.0 million in Q4 2022 to a low of -$8.3 million in Q4 2025.
• Historically, EBITDA has averaged -$301999.3 across 5 years, with a median of $178655.4 in 2026.
• The sharpest annual moves came in 2022 and 2025: EBITDA surged 239.99% in 2022, then tumbled 1940.64% in 2025.
• A 5-year view of EBITDA shows it stood at $4.0 million in 2022, then sank by 137.68% to -$1.5 million in 2023, then jumped by 130.01% to $450985.0 in 2024, then sank by 1940.64% to -$8.3 million in 2025, then soared by 102.15% to $178655.4 in 2026.
• The last three EBITDA figures came in at $178655.4 (Q1 2026), -$8.3 million (Q4 2025), and -$751340.6 (Q3 2025), per Business Quant data.